Effects of S-adenosyl-L-methionine on blood platelet activation

General Pharmacology

Volumn 29, Issue 4, 1997, Pages 651-655

  De La Cruz, J P ^a   Merida M ^a   Gonzalez Correa J A ^a   Ortiz, P ^a   De La Cuesta, F Sánchez ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Aggregation; Platelet; S adenosyl L methionine

Indexed keywords

GLUTATHIONE; S ADENOSYLMETHIONINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 17144458813     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00571-X     Document Type: Article

References (18)

1. Anderson M. E. Enzymatic and chemical methods for the determination of glutathione. Dolphin D., Poulson R., Avramovic O. Glutathione. Chemical, Biochemical and Medical Aspects:1989;339-365 Wiley, New York.
2. Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21(suppl. 97):1968;77-78.
3. Cardinal D. C., Flower R. J. The electronic aggregometer. a novel device for assessing platelet behavior in blood J. Pharmac. Methods. 3:1980;135-158.
4. De La Cruz J. P., Camara S., Bellido Y., Carrasco T., Sánchez de la Cuesta F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb. Res. 46:1986;133-146.
5. De La Cruz J. P., Ortega G., Sánchez de la Cuesta F. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity. Biochem. Pharmac. 47:1994;209-215.
6. De La Cruz J. P., Pavia J., Bellido I., Gonzalez M. C., Sánchez de la Cuesta F. Platelet antiaggregatory effect of triflusal in human whole blood. Methods Find. Exp. Clin. Pharmac. 10:1988;273-277.
7. De La Cruz J. P., Romero M., Sanchez P., Sánchez de la Cuesta F. Antiplatelet effect of pentoxifylline in human whole blood. Gen. Pharmac. 24:1993;605-609.
8. Friedel H. A., Goa K. L., Benfield P. S-Adenosyl-L-methionine. Drugs. 38:1989;389-416.
9. Giulidori P., Galli-Kienle M., Katio E., Stramentinoli G. Transmethylation, transulfuration and aminopropylation reactions of S-adenosyl-L-methionine in vivo. J. Biol. Chem. 259:1984;4205-4211.
10. González-Correa J. A., De La Cruz J. P., Galvez J., Sánchez de la Cuesta F. Effects of adenosyl-L-methionine on the liver oxidative stress in an experimental model of extrahepatic biliary obstruction. Pharmac. Res. 31(suppl. 1):1995;219.
11. Gresele P., Zoja C., Deckmyn H., Arnout J., Vermylen J., Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb. Haemostasis. 50:1983;852-856.
12. Laffi G., Lavilla G., Pinzani M.et al. Altered renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology. 90:1986;274-282.
13. Moncada S., Gryglewski R., Bunting S., Vane J. R. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxide (prostaglandin X) which prevents platelet aggregation. Prostaglandins. 12:1976;715-738.
14. Moncada S., Higgs E. A. Endogenous nitric oxide physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21:1991;361-374.
15. Muriel P., Suarez O. R., Gonzalez P., Zuñiga L. Protective effect of S-adenosyl-L-methionine on liver damage induced by biliary obstruction in rats. a histological, ultrastructural and biochemical approach J. Hepatol. 21:1994;95-105.
16. Roos H., Pleger K. Kinetics of adenosine uptake by erythrocytes and the influence of dipyridamole. Mol. Pharmac. 8:1972;417-425.
17. Santos M. T., Valles J., Aznar J., Perez-Requejo J. L. Role of red blood cells in the early stage of platelet activation by collagen. Thromb. Haemostasis. 56:1986;376-381.
18. Schattner M. A., Geffner J. R., Isturiz M. A., Lazzari M. A. Inhibition of human platelet activation by polymorphonuclear leukocytes. Br. J. Pharmac. 101:1990;253-256.